Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 197

1.

Guideline-concordant antibiotic therapy and clinical outcomes in healthcare-associated pneumonia.

Webb BJ, Dangerfield BS, Pasha JS, Agrwal N, Vikram HR.

Respir Med. 2012 Nov;106(11):1606-12. doi: 10.1016/j.rmed.2012.08.003. Epub 2012 Aug 21.

2.
3.

Impact of guideline-consistent therapy on outcome of patients with healthcare-associated and community-acquired pneumonia.

Grenier C, PĂ©pin J, Nault V, Howson J, Fournier X, Poirier MS, Cabana J, Craig C, Beaudoin M, Valiquette L.

J Antimicrob Chemother. 2011 Jul;66(7):1617-24. doi: 10.1093/jac/dkr176. Epub 2011 May 17.

PMID:
21586592
4.

Guideline-concordant antibiotic use and survival among patients with community-acquired pneumonia admitted to the intensive care unit.

Frei CR, Attridge RT, Mortensen EM, Restrepo MI, Yu Y, Oramasionwu CU, Ruiz JL, Burgess DS.

Clin Ther. 2010 Feb;32(2):293-9. doi: 10.1016/j.clinthera.2010.02.006.

PMID:
20206787
5.

Clinical impact of broad-spectrum empirical antibiotic therapy in patients with healthcare-associated pneumonia: a multicenter interventional study.

Falcone M, Corrao S, Licata G, Serra P, Venditti M.

Intern Emerg Med. 2012 Dec;7(6):523-31. doi: 10.1007/s11739-012-0795-8. Epub 2012 Jun 12.

PMID:
22688529
6.

Impact of guideline-concordant empiric antibiotic therapy in community-acquired pneumonia.

Frei CR, Restrepo MI, Mortensen EM, Burgess DS.

Am J Med. 2006 Oct;119(10):865-71.

PMID:
17000218
7.

A new strategy for healthcare-associated pneumonia: a 2-year prospective multicenter cohort study using risk factors for multidrug-resistant pathogens to select initial empiric therapy.

Maruyama T, Fujisawa T, Okuno M, Toyoshima H, Tsutsui K, Maeda H, Yuda H, Yoshida M, Kobayashi H, Taguchi O, Gabazza EC, Takei Y, Miyashita N, Ihara T, Brito V, Niederman MS.

Clin Infect Dis. 2013 Nov;57(10):1373-83. doi: 10.1093/cid/cit571. Epub 2013 Sep 2.

PMID:
23999080
8.

Guideline-concordant therapy and outcomes in healthcare-associated pneumonia.

Attridge RT, Frei CR, Restrepo MI, Lawson KA, Ryan L, Pugh MJ, Anzueto A, Mortensen EM.

Eur Respir J. 2011 Oct;38(4):878-87. doi: 10.1183/09031936.00141110. Epub 2011 Mar 24.

9.

The definition of healthcare-associated pneumonia (HCAP) is insufficient for the medical environment in Japan: a comparison of HCAP and nursing and healthcare-associated pneumonia (NHCAP).

Kaku N, Yanagihara K, Morinaga Y, Izumikawa K, Nagashima S, Kakeya H, Yamamoto Y, Fukuda M, Takatani H, Fukuda M, Hashiguchi K, Kohno S.

J Infect Chemother. 2013 Feb;19(1):70-6. doi: 10.1007/s10156-012-0454-z. Epub 2012 Aug 1.

PMID:
22850821
10.

Effect of antibiotic guidelines on outcomes of hospitalized patients with nursing home-acquired pneumonia.

El Solh AA, Akinnusi ME, Alfarah Z, Patel A.

J Am Geriatr Soc. 2009 Jun;57(6):1030-5. doi: 10.1111/j.1532-5415.2009.02279.x. Epub 2009 Apr 30.

PMID:
19460091
11.

Healthcare-associated pneumonia: diagnostic criteria and distinction from community-acquired pneumonia.

Falcone M, Venditti M, Shindo Y, Kollef MH.

Int J Infect Dis. 2011 Aug;15(8):e545-50. doi: 10.1016/j.ijid.2011.04.005. Epub 2011 May 26. Review.

12.

Predicting risk of drug-resistant organisms in pneumonia: moving beyond the HCAP model.

Webb BJ, Dascomb K, Stenehjem E, Dean N.

Respir Med. 2015 Jan;109(1):1-10. doi: 10.1016/j.rmed.2014.10.017. Epub 2014 Nov 13. Review.

13.

Comparison of severe healthcare-associated pneumonia with severe community-acquired pneumonia.

Jeong BH, Jeon EJ, Yoo H, Koh WJ, Suh GY, Chung MP, Kwon OJ, Jeon K.

Lung. 2014 Apr;192(2):313-20. doi: 10.1007/s00408-013-9541-x. Epub 2013 Dec 1.

PMID:
24292398
14.

Guideline adherence and macrolides reduced mortality in outpatients with pneumonia.

Asadi L, Eurich DT, Gamble JM, Minhas-Sandhu JK, Marrie TJ, Majumdar SR.

Respir Med. 2012 Mar;106(3):451-8. doi: 10.1016/j.rmed.2011.11.017. Epub 2011 Dec 17.

15.

Clinical features of healthcare-associated pneumonia (HCAP) in a Japanese community hospital: comparisons among nursing home-acquired pneumonia (NHAP), HCAP other than NHAP, and community-acquired pneumonia.

Umeki K, Tokimatsu I, Yasuda C, Iwata A, Yoshioka D, Ishii H, Shirai R, Kishi K, Hiramatsu K, Matsumoto B, Kadota J.

Respirology. 2011 Jul;16(5):856-61. doi: 10.1111/j.1440-1843.2011.01983.x.

PMID:
21545370
16.

Low incidence of multidrug-resistant organisms in patients with healthcare-associated pneumonia requiring hospitalization.

Garcia-Vidal C, Viasus D, Roset A, Adamuz J, Verdaguer R, Dorca J, Gudiol F, CarratalĂ  J.

Clin Microbiol Infect. 2011 Nov;17(11):1659-65. doi: 10.1111/j.1469-0691.2011.03484.x. Epub 2011 Apr 4.

17.

Poor prediction of potentially drug-resistant pathogens using current criteria of health care-associated pneumonia.

Park SC, Kang YA, Park BH, Kim EY, Park MS, Kim YS, Kim SK, Chang J, Jung JY.

Respir Med. 2012 Sep;106(9):1311-9. doi: 10.1016/j.rmed.2012.04.003. Epub 2012 May 4.

18.

Clinical and microbiological evaluation of hemodialysis-associated pneumonia (HDAP): should HDAP be included in healthcare-associated pneumonia?

Kawasaki S, Aoki N, Kikuchi H, Nakayama H, Saito N, Shimada H, Miyazaki S, Sakai S, Suzuki M, Narita I.

J Infect Chemother. 2011 Oct;17(5):640-5. doi: 10.1007/s10156-011-0228-z. Epub 2011 Mar 3.

PMID:
21369775
19.
20.

The HCAP gap: differences between self-reported practice patterns and published guidelines for health care-associated pneumonia.

Seymann GB, Di Francesco L, Sharpe B, Rohde J, Fedullo P, Schneir A, Fee C, Chan KM, Fatehi P, Dam TT.

Clin Infect Dis. 2009 Dec 15;49(12):1868-74. doi: 10.1086/648429.

PMID:
19911940

Supplemental Content

Support Center